Business

DGHS bans reuse of single‑use medical devices in Indian hospitals

NEWZA Editorial Team•

⚡ Key Financial Takeaways

  • The DGHS directive, dated Oct 16, bars the re‑processing and reuse of single‑use medical devices (SUDs) in every Indian health‑care setting.
  • Medical‑device associations MTaI and AiMeD praised the ban, warning that reuse can cause infections, device failure and legal liability for the re‑using establishment.
  • AiMeD called for regular inspections, traceable usage records, strict enforcement under the Medical Devices Rules 2017 and Clinical Establishments Act 2010, and training on infection control.
  • The industry stresses that effective implementation and patient awareness are crucial for the directive’s success.
  • The move aligns India with global patient‑safety standards and may spur demand for affordable, truly single‑use alternatives.

💡 Why It Matters

Reusing single‑use medical devices can expose patients to infections and device failures, undermining trust in health‑care delivery. The DGHS ban formalises a safety standard that protects patients, clarifies legal responsibility, and brings India in line with global best practices, potentially reducing litigation and improving overall health outcomes.

DGHS issues nationwide ban on re‑using disposable medical items The Directorate General of Health Services (DGHS) released a directive on 16 October ordering all states, Union Territories, regulators and health agencies to stop the reuse of single‑use medical devices (SUDs) and disposable surgical supplies in both public and private hospitals.

Industry reaction underscores safety concerns The Medical Technology Association of India (MTaI) welcomed the order, describing it as a "significant step towards strengthening patient safety and improving outcomes." The association cautioned that the ban will only be effective if state authorities, regulators and health‑care providers enforce it consistently and if patients are made aware of the risks.

The Association of Indian Medical Device Industry (AiMeD) echoed the sentiment, labeling the directive a "patient‑first" intervention. AiMeD highlighted that SUDs are not engineered for cleaning, resterilisation or repeated use, and that such practices can lead to cross‑infection, loss of performance and potential harm.

> "Single‑use means single‑use. When a product is used contrary to its labelled instructions, any failure or harm cannot be attributed to the manufacturer. Responsibility must rest with the person or establishment that reused it," said Rajiv Nath, forum coordinator at AiMeD.

Calls for robust enforcement and clear liability AiMeD urged the government to define liability clearly for breaches of the ban and to conduct regular inspections of health‑care establishments. The body also recommended maintaining traceable records of device usage and disposal, enforcing the Medical Devices Rules 2017 and the Clinical Establishments Act 2010, and providing training on infection‑prevention and biomedical waste management.

To prevent economic pressures from driving reuse, AiMeD advocated for the wider availability of safe, affordable single‑use alternatives.

What the ban means for Indian health‑care The directive is expected to tighten scrutiny of hospital practices related to device handling and infection control. By aligning with international patient‑safety norms, it reinforces the principle that medical devices must be used strictly as per manufacturers’ instructions, thereby reducing the risk of device‑related complications and legal disputes.

--- *The article references statements released by MTaI and AiMeD and the DGHS directive issued on 16 October.*

🏛️ Background & Context

India has faced periodic reports of hospitals re‑processing disposable medical items to cut costs, raising concerns among regulators and patient‑advocacy groups. The Medical Devices Rules 2017 and the Clinical Establishments Act 2010 already set standards for device usage, but enforcement has varied across states. This directive seeks to standardise compliance nationwide.

👁️ What To Watch Next

Monitoring by state health departments for compliance audits, any legal actions arising from violations, and market responses such as the launch of lower‑cost single‑use alternatives. Further guidance on enforcement mechanisms from the DGHS is also anticipated.

Topics:#Health policy#Medical devices#Patient safety#India#DGHS

More in Business

Back to Home